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Owing to continuous developments of high throughput experimental technologies, projects are going on not only to 
determine complete genome sequences of an increasing number of organisms, but also to analyze gene expression 
profiles both at the mRNA and protein levels and to catalog protein 3D structure families. Bioinformatics provides basic 
concepts as well as practical methods to go up from the molecular level to the cellular level, and eventually to still 
higher levels, to that of biological systems by analyzing complex interactions among building blocks and with dynamic 
environments. We have been developing such bioinformatics technologies and the KEGG system (http://www.genome.
jp/kegg/), which is our attempt to uncover and utilize cellular functions through the reconstruction of protein interaction 
networks from genome information.
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KEGG DRUG Database
Chemical genomics is the next stage of post-genomic 
analysis. Drugs, environmental substances and various 
chemical compounds contribute to the fluctuation of bio-
system. Therefore, chemical genomic analysis would re-
quire the investigation of relationships between genomes 
and their external compounds.
These relationships between bio-systems and external 
compounds include interaction between cell and drug. At 
present, discovery of new drugs with desired physico-
chemical and biological properties has been a long-standing 
challenge in pharmaceutical researches. Most of current 
drugs have evolved from original compounds found by 
chance through empirical screening. In the process of this 
evolution, continuous modifications have been made in an 
empirical manner to optimize targets to new molecules 
with better efficacy. It is possible to extract such a manner 
from a lot of data.
The KEGG DRUG database is a new addition to the 
KEGG LIGAND database, which contains the chemical 
structures of drugs and additional information such as 
therapeutic categories and target molecules. In particular, 
the KEGG DRUG Structure Map graphically illustrates our 
knowledge on drug development on the basis of chronolo-
gy, targets and skeletons. This useful information must help 
new drug discovery.
GENIES: Gene Network Inference Engine 
Based on Supervised Analysis
The GENIES is a newly developed system to infer a 
global gene network consisting of functional associations 
between genes based on various genomic information and 
high-throughput experimental data (e.g., gene positions, 
phylogenetic profiles, gene expression profiles and protein 
intracellular localization) in the framework of supervised 
network inference. Figure 2 shows an illustration of the 
procedure in the GENEIS. The GENIES enables us to 
predict unknown functional relationships between genes, 
and fill in the pathway holes by selecting candidate genes 
coding for missing enzymes in metabolic pathways.
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Figure 1. The KEGG DRUG Structure Map. Figure 2. Various genome-wide datasets are used for predicting a global 
gene network.
